Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-05-19 @ 9:16 AM
Study NCT ID:
NCT01637532
Status:
COMPLETED
Last Update Posted:
2016-01-26
First Post:
2012-04-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer
Sponsor:
Organization: